Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa   Nigi Laura   Patti Aurora   Fondelli Cecilia   Dotta Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite

Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus

By Papanas Nikolaos   Katsiki Niki   Hatzitolios Apostolos I   Maltezos Efstratios  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1457-1461

Informa Healthcare

Access to resources Recommend Favorite

Achievement of Lipid Targets with the Combination of Rosuvastatin and Fenofibric Acid in Patients with Type 2 Diabetes Mellitus

By Rosenson Robert   Carlson Dawn   Kelly Maureen   Setze Carolyn   Hirshberg Boaz   Stolzenbach James   Williams Laura  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 47-57

Springer Publishing Company

Access to resources Recommend Favorite

Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective

By Neeser K.  

PharmacoEconomics, Vol. 22, Iss. 5, 2004-01 ,pp. : 321-341

Adis International

Access to resources Recommend Favorite

Combination therapy in type 2 diabetes mellitus: adding linagliptin to a stable regimen of metformin and a sulfonylurea

By Aronson Ronnie  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 10, 2012-07 ,pp. : 1535-1539

Informa Healthcare

Access to resources Recommend Favorite